A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder
PHASE3CompletedINTERVENTIONAL
Enrollment
158
Participants
Timeline
Start Date
Not specified
Study Completion Date
April 30, 1999
Conditions
Bipolar DisordersManic Disorder
Interventions
DRUG
risperidone
All Listed Sponsors
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.